Literature DB >> 21830965

Combination drugs--hype, harm, and hope.

Scott H Podolsky1, Jeremy A Greene.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21830965     DOI： 10.1056/NEJMp1106161

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  Revisiting the isobole and related quantitative methods for assessing drug synergism.

Authors:  Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2012-04-17       Impact factor: 4.030

2.  Are drug combinations safe in the pediatric practice?

Authors:  Siba Prosad Paul; Abigail Mee; Anil Kumar Garg
Journal:  Indian J Pediatr       Date:  2012-02-23       Impact factor: 1.967

Review 3.  Challenges and opportunities in achieving bioequivalence for fixed-dose combination products.

Authors:  Amitava Mitra; Yunhui Wu
Journal:  AAPS J       Date:  2012-06-09       Impact factor: 4.009

4.  "Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy.

Authors:  Bart Hens; Maura Corsetti; Marival Bermejo; Raimar Löbenberg; Pablo M González; Amitava Mitra; Divyakant Desai; Dakshina Murthy Chilukuri; Alexis Aceituno
Journal:  AAPS J       Date:  2019-06-06       Impact factor: 4.009

Review 5.  Evaluation of synergism in drug combinations and reference models for future orientations in oncology.

Authors:  Diana Duarte; Nuno Vale
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-05-12

6.  CISNE: An accurate description of dose-effect and synergism in combination therapies.

Authors:  Amador García-Fuente; Fernando Vázquez; José M Viéitez; Francisco J García Alonso; José I Martín; Jaime Ferrer
Journal:  Sci Rep       Date:  2018-03-21       Impact factor: 4.379

7.  Pairwise combinations of chemical compounds that delay yeast chronological aging through different signaling pathways display synergistic effects on the extent of aging delay.

Authors:  Pamela Dakik; Mélissa McAuley; Marisa Chancharoen; Darya Mitrofanova; Monica Enith Lozano Rodriguez; Jennifer Anne Baratang Junio; Vicky Lutchman; Berly Cortes; Éric Simard; Vladimir I Titorenko
Journal:  Oncotarget       Date:  2019-01-08

8.  Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction.

Authors:  Lei Huang; David Brunell; Clifford Stephan; James Mancuso; Xiaohui Yu; Bin He; Timothy C Thompson; Ralph Zinner; Jeri Kim; Peter Davies; Stephen T C Wong
Journal:  Bioinformatics       Date:  2019-10-01       Impact factor: 6.937

Review 9.  Analysis of drug combinations: current methodological landscape.

Authors:  Julie Foucquier; Mickael Guedj
Journal:  Pharmacol Res Perspect       Date:  2015-05-20

Review 10.  Combination therapeutics in complex diseases.

Authors:  Bing He; Cheng Lu; Guang Zheng; Xiaojuan He; Maolin Wang; Gao Chen; Ge Zhang; Aiping Lu
Journal:  J Cell Mol Med       Date:  2016-09-07       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.